GUIDE FOR INFORMED CONSENT V Oct 2014

GUIDE-FOR-INFORMED-CONSENT-V-Oct-2014

User Manual: Pdf

Open the PDF directly: View PDF PDF.
Page Count: 3

Research Oversight and Compliance Office UofT REB Informed Consent Guide
Human Research Ethics Program
V: Oct 2014
1
GUIDE FOR INFORMED CONSENT
Consent to participate in a research study should be understood as a process rather than an
event. Researchers should plan for and articulate the steps by which consent is initially
obtained and the steps by which it is reviewed throughout the study. In order for participants
to give meaningful consent, they should be able to understand the intent of the research, be
clear about what they are being asked to do and if any risks are involved, and know how their
information will be used.
Consent may be documented in many ways. Oral or implied consent are as legitimate as written
consent, and in some contexts may even be more appropriate. For example, oral consent may
be more appropriate than written consent if literacy, criminality or cultural appropriateness is
an issue. The key idea is to go over the information verbally and document the process of
gaining consent in field notes so as to leave a written trail. It is still reasonable to leave written
material with the participant (e.g., an information letter). Regardless of the way in which
consent is sought or documented, the primary focus of ethical concern should be on the quality
of the consent. Consent should always be in language that is understandable and not legalistic
or too scientific, and the consent process should make room for questions, as appropriate to
the research context.
In the majority of cases, where a written-and-signed approach to consent is used, the
information letter and consent form are best presented as one document. The information
letter should begin with an invitation to potential participants and should explain why they
have been asked to participate. The body should provide a brief (i.e., a paragraph or two), plain-
language description of the proposed research project including a description of the project and
the nature of participation. An explanation of how key ethics issues—such as consent and
confidentialitywill be handled, along with a discussion of risks and benefits, and
compensation if any, should follow. The information letter should be written as if it was being
sent from the researcher to the participant, that is, in the 2nd person. It should include an
introduction of the researchers and their affiliations.
The consent portion of the Information and Consent Form should include a brief summary of
what will happen from the participant’s perspectivewithout redundancy. It should note that
the study has been explained to the participant, and the participant has had a chance to have
his or her questions answered. The basic elements of consent, bulleted below, are typically
relevant regardless of process whether written in hard copy, via e-mail, on the web, or
presented verbally in person or over the phone. However, not all items are appropriate for all
protocols, and some additional items may be requested by an REB on a case-by-case basis.
General points
Letters are presented on letterhead of the department/organization undertaking the research
The language level is appropriate to the age and reading level of the participant population
Research Oversight and Compliance Office UofT REB Informed Consent Guide
Human Research Ethics Program
V: Oct 2014
2
Affiliation and contact information for the investigators and (where appropriate) research
coordinator is included
• Any co-existing roles that might be understood as creating conflict of interest and how these
will be managed are explained
A sentence explains that participants can contact the Research Oversight and Compliance
Office - Human Research Ethics Program at ethics.review@utoronto.ca or 416-946-3273, if
they have questions about their rights as participants
Participants are given a copy of the information letter to keep for their own reference (this
may be implicit)
Introductory information
An invitation to participate should be worded in a professional and respectful manner
The purpose of the research should be consistent with that described in the ethics application
form
The sponsor of the research may be relevant, particularly if this might affect consent (e.g.,
industry funded, military funding)
The time commitment and the location of where the study will be conducted should be
clarified
The reason why the potential participant is being approached should be explained, and a list
of relevant inclusion and exclusion criteria, should be provided
If relevant, the number of participants who will be involved should be mentioned (e.g., if this
could affect confidentiality - see below)
Conditions for participating
There must be an explicit statement that the individual’s participation is voluntary, and that
he/she may refuse to participate, may withdraw at any time, and may decline to answer any
question or participate in any parts of the procedures/tasks all without negative
consequences
Any conditions on withdrawal of data if the participant chooses to withdraw from the study
should be clarified (e.g., if data are anonymized or de-linked, they cannot be withdrawn;
similarly, it is almost impossible to withdraw data from a focus group discussion)
Information regarding use of audio and video recordings (including potential use for teaching
or presentation purposes) should be broken out as separate options, to which participants
can consent (or not)
Risks/Benefits
Reasonably foreseeable risks, harms or inconveniences and how they will be managed should
be clearly explained in lay terms
Mechanisms for reporting significant risk-related issues that are identified during the study
and for providing referrals in response to these issues should be described where
Research Oversight and Compliance Office UofT REB Informed Consent Guide
Human Research Ethics Program
V: Oct 2014
3
appropriatee.g., in the discovery of unusual test results and occurrence of emotional
distress resulting from this discovery or from any other aspect of participation
• Potential benefitsincluding information that there is no direct benefit—should be
mentioned, as appropriate
Information about any payment or compensation for participation or expense reimbursement
should be mentioned (but not over-emphasized)
Access to information, confidentiality, and publication of results
Information regarding who will have access to the data should be clarified
Information regarding partnership agreements with communities who may want/have access
to or possibly ownership of the data should be discussed
Information regarding retention and disposition of the data during and after completion of
research may also be relevant. Note: destruction of data is not the only acceptable method of
disposition. Methods will depend on the identifiability, sensitivity, and richness of the data,
and the standards of the researcher’s discipline.
If relevant, different degrees of confidentiality should be presented as options
Procedures for maintaining confidentiality, should be described, if relevante.g., use of
study-specific ID numbers, pseudonyms, generic descriptors, composites, or aggregates
Any foreseeable limits to confidentiality—e.g., for participation in focus groups or research
involving key informants or duty to reportshould be mentioned
The researcher’s intent to publish or make public presentations based on the research should
be made explicit
A summary of the research results, and a mechanism to provide the summary, should be
offered
A brief notification should be added to the consent document/process to inform the
participants that a UofT representative may review their research files for quality assurance. An
example of the notification that must be provided to all participants could be: The research
study you are participating in may be reviewed for quality assurance to make sure that the
required laws and guidelines are followed. If chosen, (a) representative(s) of the Human
Research Ethics Program (HREP) may access study-related data and/or consent materials as
part of the review. All information accessed by the HREP will be upheld to the same level of
confidentiality that has been stated by the research team.”

Navigation menu